Big Pharma is openly railing against RFK Jr.’s anti-vaccine agenda

Executives in the pharmaceutical industry are no longer holding back their feelings about the controversial anti-vaccine stance promoted by Health Secretary Robert F. Kennedy Jr. Recent discussions at the J.P. Morgan Healthcare Conference in San Francisco revealed a growing frustration among these leaders, particularly from Pfizer CEO Albert Bourla. Bourla expressed his annoyance and disappointment, stating, "I am very annoyed. I’m very disappointed. I’m seriously frustrated. What is happening has zero scientific merit and is just serving an agenda which is political, and then antivax." This candid criticism comes against the backdrop of Kennedy's recent announcement regarding a significant alteration to the childhood vaccination schedule, which has reduced the recommended vaccines from 17 to 11. This sudden and drastic decision has raised eyebrows, particularly because it bypassed the usual scientific review processes that are essential for such changes, processes that typically take months or even years to finalize. Kennedy argued that this adjustment aligns the U.S. more closely with the vaccination schedules of peer nations, yet an analysis by Stat News indicates that the U.S. now stands out as an outlier, recommending significantly fewer vaccines than most other countries. Among 20 comparable nations analyzed, only Denmark shares a similarly low recommendation count. In response to these changes, prominent medical organizations, including the American Academy of Pediatrics, are reportedly gearing up to pursue legal action aimed at halting the proposed alterations to the vaccination schedule.